235 related articles for article (PubMed ID: 28053186)
1. AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease.
Xie C; Gong XM; Luo J; Li BL; Song BL
J Lipid Res; 2017 Mar; 58(3):512-518. PubMed ID: 28053186
[TBL] [Abstract][Full Text] [Related]
2. Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1.
Chandler RJ; Williams IM; Gibson AL; Davidson CD; Incao AA; Hubbard BT; Porter FD; Pavan WJ; Venditti CP
Hum Mol Genet; 2017 Jan; 26(1):52-64. PubMed ID: 27798114
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.
Torres S; Matías N; Baulies A; Nuñez S; Alarcon-Vila C; Martinez L; Nuño N; Fernandez A; Caballeria J; Levade T; Gonzalez-Franquesa A; Garcia-Rovés P; Balboa E; Zanlungo S; Fabrías G; Casas J; Enrich C; Garcia-Ruiz C; Fernández-Checa JC
Redox Biol; 2017 Apr; 11():60-72. PubMed ID: 27888692
[TBL] [Abstract][Full Text] [Related]
4. Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice.
Davidson CD; Gibson AL; Gu T; Baxter LL; Deverman BE; Beadle K; Incao AA; Rodriguez-Gil JL; Fujiwara H; Jiang X; Chandler RJ; Ory DS; Gradinaru V; Venditti CP; Pavan WJ
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34407999
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.
Roszell BR; Tao JQ; Yu KJ; Gao L; Huang S; Ning Y; Feinstein SI; Vite CH; Bates SR
PLoS One; 2013; 8(7):e67084. PubMed ID: 23843985
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy in a Mouse Model of Niemann-Pick Disease Type C1.
Kurokawa Y; Osaka H; Kouga T; Jimbo E; Muramatsu K; Nakamura S; Takayanagi Y; Onaka T; Muramatsu SI; Yamagata T
Hum Gene Ther; 2021 Jun; 32(11-12):589-598. PubMed ID: 33256498
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics study with mutation shows that N-terminal domain structural re-orientation in Niemann-Pick type C1 is required for proper alignment of cholesterol transport.
Yoon HJ; Jeong H; Lee HH; Jang S
J Neurochem; 2021 Mar; 156(6):967-978. PubMed ID: 32880929
[TBL] [Abstract][Full Text] [Related]
8. Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder.
Lopez ME; Klein AD; Dimbil UJ; Scott MP
J Neurosci; 2011 Mar; 31(12):4367-78. PubMed ID: 21430138
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2.
Markmann S; J Christie-Reid J; Rosenberg JB; De BP; Kaminsky SM; Crystal RG; Sondhi D
Exp Neurol; 2018 Aug; 306():22-33. PubMed ID: 29655638
[TBL] [Abstract][Full Text] [Related]
10. Genetic and pharmacological evidence implicates cathepsins in Niemann-Pick C cerebellar degeneration.
Chung C; Puthanveetil P; Ory DS; Lieberman AP
Hum Mol Genet; 2016 Apr; 25(7):1434-46. PubMed ID: 26908626
[TBL] [Abstract][Full Text] [Related]
11. A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.
Maue RA; Burgess RW; Wang B; Wooley CM; Seburn KL; Vanier MT; Rogers MA; Chang CC; Chang TY; Harris BT; Graber DJ; Penatti CA; Porter DM; Szwergold BS; Henderson LP; Totenhagen JW; Trouard TP; Borbon IA; Erickson RP
Hum Mol Genet; 2012 Feb; 21(4):730-50. PubMed ID: 22048958
[TBL] [Abstract][Full Text] [Related]
12. Overview of clinical, molecular, and therapeutic features of Niemann-Pick disease (types A, B, and C): Focus on therapeutic approaches.
Hosseini K; Fallahi J; Razban V; Sirat RZ; Varasteh M; Tarhriz V
Cell Biochem Funct; 2024 Jun; 42(4):e4028. PubMed ID: 38715125
[TBL] [Abstract][Full Text] [Related]
13. Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation.
Dominko K; Rastija A; Sobocanec S; Vidatic L; Meglaj S; Lovincic Babic A; Hutter-Paier B; Colombo AV; Lichtenthaler SF; Tahirovic S; Hecimovic S
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948052
[TBL] [Abstract][Full Text] [Related]
14. A Novel Small
Hughes MP; Nelvagal HR; Coombe-Tennant O; Smith D; Smith C; Massaro G; Poupon-Bejuit L; Platt FM; Rahim AA
Cells; 2023 Jun; 12(12):. PubMed ID: 37371089
[TBL] [Abstract][Full Text] [Related]
15. LC3 Immunostaining in the Inferior Olivary Nuclei of Cats With Niemann-Pick Disease Type C1 Is Associated With Patterned Purkinje Cell Loss.
Gurda BL; Bagel JH; Fisher SJ; Schultz ML; Lieberman AP; Hand P; Vite CH; Swain GP
J Neuropathol Exp Neurol; 2018 Mar; 77(3):229-245. PubMed ID: 29346563
[TBL] [Abstract][Full Text] [Related]
16. Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
Cougnoux A; Cluzeau C; Mitra S; Li R; Williams I; Burkert K; Xu X; Wassif CA; Zheng W; Porter FD
Cell Death Dis; 2016 Mar; 7(3):e2147. PubMed ID: 26986514
[TBL] [Abstract][Full Text] [Related]
17. AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease.
Hughes MP; Smith DA; Morris L; Fletcher C; Colaco A; Huebecker M; Tordo J; Palomar N; Massaro G; Henckaerts E; Waddington SN; Platt FM; Rahim AA
Hum Mol Genet; 2018 Sep; 27(17):3079-3098. PubMed ID: 29878115
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage.
Ilnytska O; Lai K; Gorshkov K; Schultz ML; Tran BN; Jeziorek M; Kunkel TJ; Azaria RD; McLoughlin HS; Waghalter M; Xu Y; Schlame M; Altan-Bonnet N; Zheng W; Lieberman AP; Dobrowolski R; Storch J
J Biol Chem; 2021 Jul; 297(1):100813. PubMed ID: 34023384
[TBL] [Abstract][Full Text] [Related]
19. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
[TBL] [Abstract][Full Text] [Related]
20. Altered vitamin E status in Niemann-Pick type C disease.
Ulatowski L; Parker R; Davidson C; Yanjanin N; Kelley TJ; Corey D; Atkinson J; Porter F; Arai H; Walkley SU; Manor D
J Lipid Res; 2011 Jul; 52(7):1400-10. PubMed ID: 21550990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
